{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:03:29Z","timestamp":1769555009996,"version":"3.49.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20374"],"award-info":[{"award-number":["U21A20374"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82141129"],"award-info":[{"award-number":["82141129"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82141104"],"award-info":[{"award-number":["82141104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-024-01107-5","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T11:02:15Z","timestamp":1722337335000},"page":"1522-1534","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison among different preclinical models derived from the same patient with a non-functional pancreatic neuroendocrine tumor"],"prefix":"10.1007","volume":"37","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desheng","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianjun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunrong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"issue":"6","key":"1107_CR1","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/nm.4341","volume":"23","author":"DS Rickman","year":"2017","unstructured":"Rickman DS, et al. Biology and evolution of poorly differentiated neuroendocrine tumors. Nat Med. 2017;23(6):664\u201373.","journal-title":"Nat Med"},{"issue":"1","key":"1107_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000445165","volume":"104","author":"M Milione","year":"2017","unstructured":"Milione M, et al. The clinicopathologic heterogeneity of grade 3 gastroenteropancreatic neuroendocrine neoplasms: morphological differentiation and proliferation identify different prognostic categories. Neuroendocrinology. 2017;104(1):85\u201393.","journal-title":"Neuroendocrinology"},{"issue":"11","key":"1107_CR3","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1111\/j.1572-0241.2003.07704.x","volume":"98","author":"L Gullo","year":"2003","unstructured":"Gullo L, et al. Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study. Am J Gastroenterol. 2003;98(11):2435\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"1107_CR4","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335\u201342.","journal-title":"JAMA Oncol"},{"issue":"1","key":"1107_CR5","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1038\/s41467-022-29857-6","volume":"13","author":"X Shi","year":"2022","unstructured":"Shi X, et al. Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug sensitivity. Nat Commun. 2022;13(1):2169.","journal-title":"Nat Commun"},{"issue":"2","key":"1107_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12022-016-9429-4","volume":"27","author":"Z Yang","year":"2016","unstructured":"Yang Z, et al. Establishment and characterization of a human neuroendocrine tumor xenograft. Endocr Pathol. 2016;27(2):97\u2013103.","journal-title":"Endocr Pathol"},{"issue":"5","key":"1107_CR7","first-page":"596","volume":"71","author":"M Kaku","year":"1980","unstructured":"Kaku M, et al. Establishment of a carcinoembryonic antigen-producing cell line from human pancreatic carcinoma. Gan. 1980;71(5):596\u2013601.","journal-title":"Gan"},{"issue":"2","key":"1107_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0016-5085(91)90004-5","volume":"101","author":"BM Evers","year":"1991","unstructured":"Evers BM, et al. Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology. 1991;101(2):303\u201311.","journal-title":"Gastroenterology"},{"key":"1107_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1749-6632.1994.tb17289.x","volume":"733","author":"BM Evers","year":"1994","unstructured":"Evers BM, et al. The human carcinoid cell line, BON. A model system for the study of carcinoid tumors. Ann N Y Acad Sci. 1994;733:393\u2013406.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"1107_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/00006676-200101000-00016","volume":"22","author":"LG Tillotson","year":"2001","unstructured":"Tillotson LG, et al. Isolation, maintenance, and characterization of human pancreatic islet tumor cells expressing vasoactive intestinal peptide. Pancreas. 2001;22(1):91\u20138.","journal-title":"Pancreas"},{"issue":"3","key":"1107_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/jcp.21135","volume":"213","author":"C Jonnakuty","year":"2007","unstructured":"Jonnakuty C, Gragnoli C. Karyotype of the human insulinoma CM cell line\u2013beta cell model in vitro? J Cell Physiol. 2007;213(3):661\u20132.","journal-title":"J Cell Physiol"},{"issue":"3","key":"1107_CR12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1158\/1541-7786.MCR-17-0163","volume":"16","author":"D Benten","year":"2018","unstructured":"Benten D, et al. Establishment of the first well-differentiated human pancreatic neuroendocrine tumor model. Mol Cancer Res MCR. 2018;16(3):496\u2013507.","journal-title":"Mol Cancer Res MCR"},{"issue":"16","key":"1107_CR13","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1073\/pnas.1600007113","volume":"113","author":"GW Krampitz","year":"2016","unstructured":"Krampitz GW, et al. Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors. Proc Natl Acad Sci USA. 2016;113(16):4464\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1107_CR14","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1007\/s13577-022-00696-3","volume":"35","author":"X Lou","year":"2022","unstructured":"Lou X, et al. Establishment and characterization of the third non-functional human pancreatic neuroendocrine tumor cell line. Hum Cell. 2022;35(4):1248\u201361.","journal-title":"Hum Cell"},{"issue":"5","key":"1107_CR15","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.cell.2020.10.023","volume":"183","author":"K Kawasaki","year":"2020","unstructured":"Kawasaki K, et al. An organoid biobank of neuroendocrine neoplasms enables genotype-phenotype mapping. Cell. 2020;183(5):1420-1435.e21.","journal-title":"Cell"},{"issue":"7\u20138","key":"1107_CR16","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cancergen.2015.04.002","volume":"208","author":"GK Boora","year":"2015","unstructured":"Boora GK, et al. Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines. Cancer Genet. 2015;208(7\u20138):374\u201381.","journal-title":"Cancer Genet"},{"issue":"12","key":"1107_CR17","first-page":"2032","volume":"31","author":"A Tarasov","year":"2015","unstructured":"Tarasov A, et al. Sambamba: fast processing of NGS alignment formats. Bioinformatics (Oxford, England). 2015;31(12):2032\u20134.","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"5","key":"1107_CR18","first-page":"589","volume":"26","author":"H Li","year":"2010","unstructured":"Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics (Oxford, England). 2010;26(5):589\u201395.","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"16","key":"1107_CR19","first-page":"2078","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, et al. The sequence alignment\/map format and SAMtools. Bioinformatics (Oxford, England). 2009;25(16):2078\u20139.","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"16","key":"1107_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16): e164.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1107_CR21","doi-asserted-by":"publisher","first-page":"D733","DOI":"10.1093\/nar\/gkv1189","volume":"44","author":"NA O'Leary","year":"2016","unstructured":"O\u2019Leary NA, et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res. 2016;44(D1):D733\u201345.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1107_CR22","doi-asserted-by":"publisher","first-page":"D916","DOI":"10.1093\/nar\/gkaa1087","volume":"49","author":"A Frankish","year":"2021","unstructured":"Frankish A, et al. GENCODE 2021. Nucleic Acids Res. 2021;49(D1):D916\u201323.","journal-title":"Nucleic Acids Res"},{"issue":"7422","key":"1107_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature11632","volume":"491","author":"GR Abecasis","year":"2012","unstructured":"Abecasis GR, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491(7422):56\u201365.","journal-title":"Nature"},{"issue":"1","key":"1107_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13073-017-0403-7","volume":"9","author":"Y Kobayashi","year":"2017","unstructured":"Kobayashi Y, et al. Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation. Genome Med. 2017;9(1):13.","journal-title":"Genome Med"},{"key":"1107_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2021.111359","volume":"534","author":"MG Pio","year":"2021","unstructured":"Pio MG, et al. Curating the gnomAD database: report of novel variants in the thyrogobulin gene using in silico bioinformatics algorithms. Mol Cell Endocrinol. 2021;534: 111359.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"1107_CR26","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry ST, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308\u201311.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1107_CR27","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG, et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 2019;47(D1):D941\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"1107_CR28","doi-asserted-by":"publisher","first-page":"D514","DOI":"10.1093\/nar\/gki033","volume":"33","author":"A Hamosh","year":"2005","unstructured":"Hamosh A, et al. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 2005;33(Database issue):D514\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1107_CR29","doi-asserted-by":"publisher","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","volume":"47","author":"A Buniello","year":"2019","unstructured":"Buniello A, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47(D1):D1005\u201312.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"1107_CR30","doi-asserted-by":"publisher","first-page":"D1049","DOI":"10.1093\/nar\/gku1179","volume":"43","author":"Gene Ontology Consortium","year":"2015","unstructured":"Gene Ontology Consortium. Gene Ontology Consortium: going forward. Nucleic Acids Res. 2015;43(Database issue):D1049\u201356.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1107_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, et al. Gene ontology: tool for the unification of biology. Gene Ontol Consort Nat Genet. 2000;25(1):25\u20139.","journal-title":"Gene Ontol Consort Nat Genet"},{"issue":"3","key":"1107_CR32","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Cambridge (Mass)). 2021;2(3):100141.","journal-title":"Innovation (Cambridge (Mass.))"},{"issue":"2","key":"1107_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182\u20138.","journal-title":"Histopathology"},{"issue":"3","key":"1107_CR34","first-page":"194","volume":"17","author":"MR Wick","year":"2000","unstructured":"Wick MR. Immunohistology of neuroendocrine and neuroectodermal tumors. Semin Diagn Pathol. 2000;17(3):194\u2013203.","journal-title":"Semin Diagn Pathol"},{"issue":"1","key":"1107_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00795-017-0167-6","volume":"51","author":"M Tanigawa","year":"2018","unstructured":"Tanigawa M, et al. Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor. Med Mol Morphol. 2018;51(1):32\u201340.","journal-title":"Med Mol Morphol"},{"issue":"5","key":"1107_CR36","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1136\/gutjnl-2018-317233","volume":"69","author":"X Hong","year":"2020","unstructured":"Hong X, et al. Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system. Gut. 2020;69(5):877\u201387.","journal-title":"Gut"},{"issue":"9","key":"1107_CR37","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41580-018-0015-0","volume":"19","author":"Y-R Lee","year":"2018","unstructured":"Lee Y-R, Chen M, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor: new modes and prospects. Nat Rev Mol Cell Biol. 2018;19(9):547\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"1107_CR38","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.5858\/arpa.2013-0195-OA","volume":"138","author":"JS Estrella","year":"2014","unstructured":"Estrella JS, et al. Progesterone receptor and PTEN expression predict survival in patients with low- and intermediate-grade pancreatic neuroendocrine tumors. Arch Pathol Lab Med. 2014;138(8):1027\u201336.","journal-title":"Arch Pathol Lab Med"},{"issue":"6021","key":"1107_CR39","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1126\/science.1200609","volume":"331","author":"Y Jiao","year":"2011","unstructured":"Jiao Y, et al. DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science (New York, NY). 2011;331(6021):1199\u2013203.","journal-title":"Science (New York, N.Y.)."},{"issue":"7643","key":"1107_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature21063","volume":"543","author":"A Scarpa","year":"2017","unstructured":"Scarpa A, et al. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature. 2017;543(7643):65\u201371.","journal-title":"Nature"},{"issue":"1","key":"1107_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105881","volume":"26","author":"T-L Kuo","year":"2023","unstructured":"Kuo T-L, et al. ARID1A loss in pancreas leads to islet developmental defect and metabolic disturbance. iScience. 2023;26(1): 105881.","journal-title":"iScience"},{"issue":"9","key":"1107_CR42","doi-asserted-by":"publisher","first-page":"957","DOI":"10.7150\/ijbs.9773","volume":"10","author":"F Yuan","year":"2014","unstructured":"Yuan F, et al. KRAS and DAXX\/ATRX gene mutations are correlated with the clinicopathological features, advanced diseases, and poor prognosis in Chinese patients with pancreatic neuroendocrine tumors. Int J Biol Sci. 2014;10(9):957\u201365.","journal-title":"Int J Biol Sci"},{"issue":"8","key":"1107_CR43","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1053\/j.gastro.2018.02.026","volume":"154","author":"S Roy","year":"2018","unstructured":"Roy S, et al. Loss of chromatin-remodeling proteins and\/or CDKN2A associates with metastasis of pancreatic neuroendocrine tumors and reduced patient survival times. Gastroenterology. 2018;154(8):2060-2063.e8.","journal-title":"Gastroenterology"},{"key":"1107_CR44","volume-title":"Current clinical topics in gastrointestinal pharmacology","author":"R Jensen","year":"1997","unstructured":"Jensen R, Lewis J, Dubois A. Current clinical topics in gastrointestinal pharmacology. Malden: Blackwell Science Inc.; 1997."},{"key":"1107_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1756-8722-4-29","volume":"4","author":"MH Kulke","year":"2011","unstructured":"Kulke MH, et al. Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumors. J Hematol Oncol. 2011;4:29.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"1107_CR46","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1056\/NEJMoa1003825","volume":"364","author":"E Raymond","year":"2011","unstructured":"Raymond E, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med. 2011;364(6):501\u201313.","journal-title":"N Engl J Med"},{"issue":"6","key":"1107_CR47","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1056\/NEJMoa1009290","volume":"364","author":"JC Yao","year":"2011","unstructured":"Yao JC, et al. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med. 2011;364(6):514\u201323.","journal-title":"N Engl J Med"},{"issue":"13","key":"1107_CR48","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1158\/0008-5472.CAN-22-3599","volume":"83","author":"J Xu","year":"2023","unstructured":"Xu J, et al. MEN1 degradation induced by neddylation and the CUL4B-DCAF7 axis promotes pancreatic neuroendocrine tumor progression. Can Res. 2023;83(13):2226\u201347.","journal-title":"Can Res"},{"key":"1107_CR49","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.029595","author":"K Kawasaki","year":"2018","unstructured":"Kawasaki K, Fujii M, Sato T. Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models. Disease Models Mech. 2018. https:\/\/doi.org\/10.1242\/dmm.029595.","journal-title":"Disease Models Mech"},{"issue":"3","key":"1107_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000509864","volume":"111","author":"K Detjen","year":"2021","unstructured":"Detjen K, et al. Models of gastroenteropancreatic neuroendocrine neoplasms: current status and future directions. Neuroendocrinology. 2021;111(3):217\u201336.","journal-title":"Neuroendocrinology"},{"issue":"12","key":"1107_CR51","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1158\/1535-7163.MCT-17-1204","volume":"17","author":"CE Chamberlain","year":"2018","unstructured":"Chamberlain CE, et al. A patient-derived xenograft model of pancreatic neuroendocrine tumors identifies sapanisertib as a possible new treatment for everolimus-resistant tumors. Mol Cancer Ther. 2018;17(12):2702\u20139.","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"1107_CR52","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","volume":"7","author":"C Pauli","year":"2017","unstructured":"Pauli C, et al. Personalized in vitro and in vivo cancer models to guide precision medicine. Cancer Discov. 2017;7(5):462\u201377.","journal-title":"Cancer Discov"},{"key":"1107_CR53","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.137809","author":"Z Dantes","year":"2020","unstructured":"Dantes Z, et al. Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology. JCI Insight. 2020. https:\/\/doi.org\/10.1172\/jci.insight.137809.","journal-title":"JCI Insight"},{"issue":"12","key":"1107_CR54","doi-asserted-by":"publisher","first-page":"E2293","DOI":"10.1073\/pnas.1612906114","volume":"114","author":"YS Zhang","year":"2017","unstructured":"Zhang YS, et al. Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors. Proc Natl Acad Sci USA. 2017;114(12):E2293\u2013302.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1107_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188466","volume":"1875","author":"H Chen","year":"2021","unstructured":"Chen H, et al. Organoid model: a new hope for pancreatic cancer treatment? Biochim Biophys Acta Rev Cancer. 2021;1875(1): 188466.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"3","key":"1107_CR56","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.stem.2017.12.009","volume":"22","author":"T Seino","year":"2018","unstructured":"Seino T, et al. Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression. Cell Stem Cell. 2018;22(3):454-467.e7.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"1107_CR57","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/cmi.2012.6","volume":"9","author":"AC Drake","year":"2012","unstructured":"Drake AC, Chen Q, Chen J. Engineering humanized mice for improved hematopoietic reconstitution. Cell Mol Immunol. 2012;9(3):215\u201324.","journal-title":"Cell Mol Immunol"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-024-01107-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-024-01107-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-024-01107-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T12:37:28Z","timestamp":1724416648000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-024-01107-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["1107"],"URL":"https:\/\/doi.org\/10.1007\/s13577-024-01107-5","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,30]]},"assertion":[{"value":"12 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that there is no conflict of interest that could be perceived as prejudicing the impartiality of this research reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"In vivo manipulations in mice were approved by the Ethics Committee of Fudan University Shanghai Cancer Center (Approval No.2023052). All experiments on animals were conducted in accordance with the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978), and the euthanasia procedures of animals were in accordance with the \"Guidelines for Euthanasia of Experimental Animals (GB\/T 39760-2021)\".","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The patient gave informed consent. The approval number of the human study issued by the Ethics Committee is NCT04927611.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}